Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

13.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.0K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

6.7K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
6.7K
Humoral Immune Responses01:36

Humoral Immune Responses

65.4K
Overview
65.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Possible co-regulation of genes associated with enhanced progression of mammary adenocarcinomas.

Immunology letters·2002
Same author

The FX enzyme is a functional component of lymphocyte activation.

Cellular immunology·2002
Same author

Presence and functions of immune components in the tumor microenvironment.

Advances in experimental medicine and biology·2002
Same author

A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma.

Journal of immunology (Baltimore, Md. : 1950)·2001
Same author

The GPI-linked Ly-6 antigen E48 regulates expression levels of the FX enzyme and of E-selectin ligands on head and neck squamous carcinoma cells.

The Journal of biological chemistry·2000
Same author

Differential expression of genes by tumor cells of a low or a high malignancy phenotype: the case of murine and human Ly-6 proteins.

Journal of cellular biochemistry. Supplement·2000
Same journal

Foreword.

Immunology today·2020
Same journal

The origin and significance of anti-DNA antibodies.

Immunology today·2014
Same journal

Mutations of class II MHC molecules.

Immunology today·2014
Same journal

Antigen processing at the molecular level.

Immunology today·2014
Same journal

Phenotypically and functionally distinct T-cell subsets in anti-tumor responses.

Immunology today·2014
Same journal

Are MHC class II-restricted cytotoxic T lymphocytes important?

Immunology today·2014
See all related articles

Related Experiment Video

Updated: Apr 22, 2026

Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

39.4K

Hybridomas from unimmunized individuals.

Y Shoenfeld1, I P Witz2

  • 1Research Unit of Autoimmune Diseases, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.

Immunology Today
|October 8, 2014
PubMed
Summary
This summary is machine-generated.

This study explores natural antibodies from non-immunized animals, highlighting their potential for diagnostics and therapeutics. Research focuses on natural autoantibodies, anti-tumor antibodies, and cell hybrids.

More Related Videos

Generation of Monoclonal Antibodies Against Natural Products
12:15

Generation of Monoclonal Antibodies Against Natural Products

Published on: April 6, 2019

10.9K
Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
10:32

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

18.3K

Related Experiment Videos

Last Updated: Apr 22, 2026

Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

39.4K
Generation of Monoclonal Antibodies Against Natural Products
12:15

Generation of Monoclonal Antibodies Against Natural Products

Published on: April 6, 2019

10.9K
Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
10:32

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

18.3K

Area of Science:

  • Immunology
  • Biotechnology

Background:

  • Hybridoma products are crucial for defining diagnostic and therapeutic markers.
  • The potential of hybridomas from naturally immunized animals remains underexplored.

Purpose of the Study:

  • To analyze natural autoantibodies and their role in autoimmunity.
  • To investigate natural anti-tumor antibodies.
  • To explore hybrids formed between host and tumor cells.

Main Methods:

  • Analysis of natural autoantibodies.
  • Characterization of natural anti-tumor antibodies.
  • Formation and analysis of somatic-tumor cell hybrids.

Main Results:

  • Discussion centered on the significance of natural autoantibodies in autoimmune diseases.
  • Natural anti-tumor antibodies were a key focus.
  • The formation of hybrids between host and tumor cells was examined.

Conclusions:

  • Natural antibodies represent a valuable, underutilized resource in medicine.
  • Further research into natural antibodies could yield novel diagnostic and therapeutic strategies.
  • Hybridoma technology can be extended to study natural immune responses and cell interactions.